Company registration number 07874760 (England and Wales)
CUTTING EDGE SURGERY LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
CUTTING EDGE SURGERY LIMITED
CONTENTS
Page
Balance sheet
1 - 2
Notes to the financial statements
3 - 7
CUTTING EDGE SURGERY LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
55,895
71,879
Current assets
Debtors
5
369,923
456,593
Cash at bank and in hand
56,548
30,793
426,471
487,386
Creditors: amounts falling due within one year
6
(100,398)
(110,962)
Net current assets
326,073
376,424
Total assets less current liabilities
381,968
448,303
Creditors: amounts falling due after more than one year
7
(25,289)
(72,126)
Provisions for liabilities
1,020
(1,925)
Net assets
357,699
374,252
Capital and reserves
Called up share capital
8
6
6
Share premium account
5,509
5,509
Profit and loss reserves
352,184
368,737
Total equity
357,699
374,252
The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true
For the financial year ended 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
The directors acknowledge their responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.
The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
CUTTING EDGE SURGERY LIMITED
BALANCE SHEET (CONTINUED)
AS AT 31 DECEMBER 2025
31 December 2025
- 2 -
The financial statements were approved by the board of directors and authorised for issue on 10 September 2026 and are signed on its behalf by:
Ms J Thom
Director
Company Registration No. 07874760
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 3 -
1
Accounting policies
Company information
Cutting Edge Surgery Limited is a private company limited by shares incorporated in England and Wales. The registered office is Montefiore Hospital, 2 Montefiore Road, Hove, East Sussex, United Kingdom, BN3 1RD.
1.1
Accounting convention
These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.
The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.
The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.
1.2
Turnover
Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.
1.3
Intangible fixed assets - goodwill
Goodwill represents the excess of the cost of acquisition of unincorporated businesses over the fair value of net assets acquired. It is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is considered to have a finite useful life and is amortised on a systematic basis over its expected life, which is 10 years.
1.4
Tangible fixed assets
Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.
Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:
Plant and equipment
25% Reducing balance
Fixtures and fittings
25% Reducing balance
Computers
25% Reducing balance
Motor vehicles
25% Reducing balance
The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.
1.5
Impairment of fixed assets
At each reporting period end date, the company reviews the carrying amounts of its tangible and intangible assets to determine whether there is any indication that those assets have suffered an impairment loss. If any such indication exists, the recoverable amount of the asset is estimated in order to determine the extent of the impairment loss (if any). Where it is not possible to estimate the recoverable amount of an individual asset, the company estimates the recoverable amount of the cash-generating unit to which the asset belongs.
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 4 -
1.6
Cash and cash equivalents
Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.
1.7
Equity instruments
Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.
1.8
Taxation
The tax expense represents the sum of the tax currently payable and deferred tax.
Current tax
The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.
Deferred tax
Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.
The carrying amount of deferred tax assets is reviewed at each reporting end date and reduced to the extent that it is no longer probable that sufficient taxable profits will be available to allow all or part of the asset to be recovered. Deferred tax is calculated at the tax rates that are expected to apply in the period when the liability is settled or the asset is realised. Deferred tax is charged or credited in the profit and loss account, except when it relates to items charged or credited directly to equity, in which case the deferred tax is also dealt with in equity. Deferred tax assets and liabilities are offset when the company has a legally enforceable right to offset current tax assets and liabilities and the deferred tax assets and liabilities relate to taxes levied by the same tax authority.
1.9
Employee benefits
The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.
1.10
Retirement benefits
Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.
1.11
Leases
Leases are classified as finance leases whenever the terms of the lease transfer substantially all the risks and rewards of ownership to the lessees. All other leases are classified as operating leases.
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
2
Employees
The average monthly number of persons (including directors) employed by the company during the year was:
2025
2024
Number
Number
Total
1
1
3
Intangible fixed assets
Goodwill
£
Cost
At 1 January 2025 and 31 December 2025
135,000
Amortisation and impairment
At 1 January 2025 and 31 December 2025
135,000
Carrying amount
At 31 December 2025
At 31 December 2024
4
Tangible fixed assets
Plant and equipment
Fixtures and fittings
Computers
Motor vehicles
Total
£
£
£
£
£
Cost
At 1 January 2025
62,857
9,109
7,993
111,514
191,473
Additions
3,007
3,007
Disposals
(1,589)
(1,589)
At 31 December 2025
62,857
7,520
11,000
111,514
192,891
Depreciation and impairment
At 1 January 2025
59,929
7,957
3,353
48,355
119,594
Depreciation charged in the year
732
168
1,699
15,790
18,389
Eliminated in respect of disposals
(987)
(987)
At 31 December 2025
60,661
7,138
5,052
64,145
136,996
Carrying amount
At 31 December 2025
2,196
382
5,948
47,369
55,895
At 31 December 2024
2,928
1,152
4,640
63,159
71,879
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
5
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
18,934
27,988
Other debtors
213,252
291,368
232,186
319,356
2025
2024
Amounts falling due after more than one year:
£
£
Other debtors
137,737
137,237
Total debtors
369,923
456,593
6
Creditors: amounts falling due within one year
2025
2024
£
£
Bank loans
9,641
10,268
Taxation and social security
47,694
81,739
Other creditors
43,063
18,955
100,398
110,962
7
Creditors: amounts falling due after more than one year
2025
2024
£
£
Bank loans and overdrafts
9,641
Other creditors
25,289
62,485
25,289
72,126
8
Called up share capital
2025
2024
£
£
Ordinary share capital
Issued and fully paid
2 Ordinary A Shares of £1 each
2
2
2 Ordinary B Shares of £1 each
2
2
1 Ordinary C Share of £1 each
1
1
1 Ordinary D Share of £1 each
1
1
6
6
CUTTING EDGE SURGERY LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 7 -
9
Related party transactions
The following amounts were outstanding at the reporting end date:
2025
2024
Amounts due from related parties
£
£
Other related parties
171,317
173,923
The above loans are unsecured, interest free and have no fixed repayment terms.
10
Directors' transactions
At the balance sheet date, there was an amount due from directors of £131,974 (2024 amount due from directors of £225,367). This loan is interest free, unsecured and no formal repayment terms have been established.